Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-25-002603
Filing Date
2025-03-10
Accepted
2025-03-10 17:05:17
Documents
56
Period of Report
2025-05-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A abbv-20250509xpre14a.htm   iXBRL PRE 14A 3313408
2 GRAPHIC abbv-20250509xpre14a_a001.jpg GRAPHIC 9212
3 GRAPHIC abbv-20250509xpre14a_a002.jpg GRAPHIC 2919
4 GRAPHIC abbv-20250509xpre14a_a003.jpg GRAPHIC 3072
5 GRAPHIC abbv-20250509xpre14a_a004.jpg GRAPHIC 1946
6 GRAPHIC abbv-20250509xpre14a_a005.jpg GRAPHIC 3593
7 GRAPHIC abbv-20250509xpre14a_a006.jpg GRAPHIC 3949
8 GRAPHIC abbv-20250509xpre14a_a007.jpg GRAPHIC 4403
9 GRAPHIC abbv-20250509xpre14a_a008.jpg GRAPHIC 2964
10 GRAPHIC abbv-20250509xpre14a_a009.jpg GRAPHIC 7934
11 GRAPHIC abbv-20250509xpre14a_a012.jpg GRAPHIC 2168
12 GRAPHIC abbv-20250509xpre14a_a013.jpg GRAPHIC 1715
13 GRAPHIC abbv-20250509xpre14a_a014.jpg GRAPHIC 1735
14 GRAPHIC abbv-20250509xpre14a_a018.jpg GRAPHIC 2184
15 GRAPHIC abbv-20250509xpre14a_a019.jpg GRAPHIC 4775
16 GRAPHIC abbv-20250509xpre14a_a020.jpg GRAPHIC 4910
17 GRAPHIC abbv-20250509xpre14a_a021.jpg GRAPHIC 5132
18 GRAPHIC abbv-20250509xpre14a_a022.jpg GRAPHIC 11878
19 GRAPHIC abbv-20250509xpre14a_a025.jpg GRAPHIC 6705
20 GRAPHIC abbv-20250509xpre14a_a026.jpg GRAPHIC 7031
21 GRAPHIC abbv-20250509xpre14a_a027.jpg GRAPHIC 8150
22 GRAPHIC abbv-20250509xpre14a_a028.jpg GRAPHIC 7168
23 GRAPHIC abbv-20250509xpre14a_a029.jpg GRAPHIC 7387
24 GRAPHIC abbv-20250509xpre14a_a030.jpg GRAPHIC 6536
25 GRAPHIC abbv-20250509xpre14a_a031.jpg GRAPHIC 4922
26 GRAPHIC abbv-20250509xpre14a_a032.jpg GRAPHIC 6073
27 GRAPHIC abbv-20250509xpre14a_a033.jpg GRAPHIC 6108
28 GRAPHIC abbv-20250509xpre14a_a034.jpg GRAPHIC 6558
29 GRAPHIC abbv-20250509xpre14a_a035.jpg GRAPHIC 4955
30 GRAPHIC abbv-20250509xpre14a_a036.jpg GRAPHIC 7289
31 GRAPHIC abbv-20250509xpre14a_a037.jpg GRAPHIC 4645
32 GRAPHIC abbv-20250509xpre14a_a038.jpg GRAPHIC 6395
33 GRAPHIC abbv-20250509xpre14a_a050.jpg GRAPHIC 54253
34 GRAPHIC abbv-20250509xpre14a_a051.jpg GRAPHIC 60902
35 GRAPHIC abbv-20250509xpre14a_a061.jpg GRAPHIC 51670
36 GRAPHIC abbv-20250509xpre14a_a062.jpg GRAPHIC 49241
37 GRAPHIC abbv-20250509xpre14a_a068.jpg GRAPHIC 8871
38 GRAPHIC abbv-20250509xpre14a_a070.jpg GRAPHIC 4444
39 GRAPHIC abbv-20250509xpre14a_bg001.jpg GRAPHIC 119451
40 GRAPHIC abbv-20250509xpre14a_bg002.jpg GRAPHIC 127978
  Complete submission text file 0001558370-25-002603.txt   7022357

Data Files

Seq Description Document Type Size
41 EX-101.SCH abbv-20250509.xsd EX-101.SCH 10070
42 EX-101.DEF abbv-20250509_def.xml EX-101.DEF 16224
43 EX-101.LAB abbv-20250509_lab.xml EX-101.LAB 30010
44 EX-101.PRE abbv-20250509_pre.xml EX-101.PRE 16006
58 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20250509xpre14a_htm.xml XML 743604
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35565 | Film No.: 25724691
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)